The Board of Directors of the American Board of Precision Medicine (ABOPM) provides strategic leadership, governance, and vision for the organization’s mission to transform healthcare through precision medicine.
Comprised of distinguished physicians, scientists, and leaders across medicine, research, technology, and healthcare innovation, the Board brings together diverse expertise to guide the advancement of personalized, data-driven medicine. Their leadership ensures that ABOPM remains at the forefront of developing standards, education, and certification pathways that prepare physicians for the next era of healthcare.
Through strategic oversight and collaboration, the Board of Directors helps advance the organization’s commitment to bridging the gap between scientific discovery and real-world clinical application of precision medicine.
Dr. Bajnath is also the founder of the Institute for Human Optimization in Maryland, where he leads a clinical practice dedicated to delivering next-generation personalized healthcare. His work integrates advanced diagnostic technologies—including genomics, biomarker analysis, microbiome science, and biometric lifestyle monitoring—to identify the root causes of complex and chronic disease and develop individualized treatment strategies.
In addition to his clinical and leadership roles, Dr. Bajnath serves as Adjunct Faculty at the George Washington University School of Medicine, directing courses in clinical genomics, proteomics, and metabolomics.
Dr. Bajnath earned his medical degree from Ross University School of Medicine and completed his Family Medicine residency at the University of Maryland. He also holds an MBA in Healthcare Services.
Board-certified in Family Medicine and Regenerative Medicine, Dr. Bajnath has additional training in Functional Medicine, Anti-Aging Medicine, clinical nutrition, medical acupuncture, and European Biological Medicine.
Through his research, clinical practice, and leadership, Dr. Bajnath remains committed to advancing a new paradigm of medicine focused on root-cause diagnostics, individualized treatment, and proactive health optimization.
The Board of Directors plays a critical role in shaping the strategic direction and long-term vision of the American Board of Precision Medicine (ABOPM).
Through their leadership, the Board ensures the organization continues advancing innovation, education, and global collaboration in precision medicine.
The Board supports the mission of ABOPM by helping to:
The Role of Multi-Omics in Precision Medicine
Modern medicine increasingly recognizes that disease is driven by complex biological interactions rather than single genetic or molecular abnormalities. Multi-omics science integrates multiple biological layers to provide a comprehensive molecular understanding of health and disease.
Genomics – The study of DNA and genetic variation that influences disease risk and treatment response.
Transcriptomics – Analysis of gene expression patterns that reveal how cells respond to disease processes.
Proteomics – Investigation of protein structures and interactions that drive biological function.
Metabolomics – Measurement of metabolic pathways that reflect cellular activity and disease states.
Microbiomics – Understanding the role of the human microbiome in immune regulation, metabolism, and chronic disease.
A Commitment to Excellence
- Advance physician training in precision medicine
- Support the development of innovative diagnostic and therapeutic approaches
- Promote ethical and responsible implementation of emerging medical technologies
- Improve patient outcomes through individualized healthcare strategies
FEATURED BLOGS
Insights Shaping Precision Medicine
Explore ABOPM perspectives on multi-omics, systems thinking, clinical innovation, and the future of physician leadership.
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.